Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for intracapsular neck of femur fractures undergoing arthroplasty
ACTRN12617000391370Phase 2Completed
- Sponsor
- Nepean Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tranexamic acid in Neck Of Femur Fracture (2 arms), sponsored by Nepean Hospital. Primary endpoint: Incidence of acute postoperative blood transfusion. Started Jan 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Neck Of Femur Fracture
Beyond the preview
Go deeper on ACTRN12617000391370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000391370.